Established in 2013, Polpharma Biologics is the biotechnology unit of the rapidly growing Polpharma Group –...
OPINION
Experts Point of View
Small companies and academic institutions develop their assets, in most cases, under budget constraints....
In December 2016, US biotech company Ionis Pharmaceuticals’ drug Spinraza received regulatory approval in the...
The decision of the European Patent Office to examine all patent applications within 12 months can...
There’s no way around it: renewables are the future, Matti Heikkilä believes. European Biotechnology talked to...
The pharmaceutical industry of the European Union is currently toiling at a veritably Herculean task. They...